We are on the cusp of a major milestone in retinal degenerative diseases, moving beyond just slowing down vision loss to actually restoring sight. What once sounded like science fiction is now taking place in clinical trials.
This podcast is not available for CME/CE/CPD credits. Please visit the Medscape homepage for accredited CME/CE/CPD activities. https://www.medscape.org/viewarticle/1002678?ecd=bdc_podcast_libsyn_mscpedu